Skip to content

Catalysts Convergence Squeeze SignalsNEW Cash Runway Insiders M&A Research

Sign In Start 14-Day Free Trial

Home›Companies›EAST WEST BANCORP INC (EWBC)

EAST WEST BANCORP INC

EWBC

Held by 1 specialist biotech fund

1 fund opened new positions. Short interest: 2.9% of float.

Share

Score Holdings Short Interest Catalysts Insiders Research

Signal Score

1.5/10

1 fund opened new positions

B

BiotechEdge

Catalysts Conferences Companies Convergence Fund Insiders Signals Squeeze Cash Runway Research Weekly Briefs 13F Changes Glossary PricingSign In Start 14-Day Free Trial

Data sourced from SEC EDGAR and ClinicalTrials.gov. Not investment advice.

EWBC: Held by 1 Biotech Hedge Fund (2026) | BiotechEdge

●●

No recent insider activity●●

No upcoming catalysts●●

Held by 1 specialist fund●●

See how each signal contributes— fund overlap, insider activity, catalyst timing, short interest (free trial)

Fund Holdings

Eventide Asset ManagementNew

AI Signal

Signal Note — EWBC | Eventide Asset Management | New Position

Eventide, a values-based manager known for biotech and mission-aligned holdings, initiated a modest $250K position in East West Bancorp (EWBC), a U.S.-China focused commercial bank — a notable sector departure from their typical healthcare/biotech allocation. The small position size suggests this may be an exploratory or ESG-screened financial sector add rather than a high-conviction core holding.

Unlock full AI analysis — 14-day free trial

Short Interest

Shorts coveringSI declining 2 periods (-20.7%)

Short Shares

3.89M

Change

-20.7%

Days to Cover

5.6

% of Float

2.9%

Settlement

Aug 14, 2026

Short interest over 3 periods

Catalysts

No catalysts tracked.

Be first to know when this name moves

Fund buys and exits, insider activity, and catalyst alerts across 800+ biotechs — free Monday brief.

Position Details

Eventide Asset ManagementNEW POSITIONAug 14, 2026

Start free trialfor share counts, dollar values & AI analysis

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 14-Day Free Trial — $29/mo

Also Held by These Funds

VFC1 fund CDNS1 fund ETNB1 fund AKRO1 fund ALGN1 fund APLS1 fund NTLA1 fund LRCX1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Related Research

Verdad's Biotech White Paper, Part 1: Why Specialist Fund Holdings Predict Returns

6 min read

Verdad's Biotech White Paper, Part 2: Why Traditional Quant Factors Fail — and What Works Instead

6 min read

Fund Convergence: The Highest-Conviction Signal in Biotech Investing

5 min read

Track specialist biotech funds, insider signals, and AI analysis

Start 14-Day Free Trial

Get free weekly alerts on fund moves and catalysts: